Toolkit provides an additional way for people to educate themselves, understand the guidelines and share knowledge
The Canadian Centre on Substance Use and Addiction (CCSA) proudly welcomes Dr. Louis Francescutti, Neil Arao, Cheryl Fraser and Dr. Dirk Huyer to its Board of Directors. Dr. Francescutti has been appointed as Chair of CCSA’s Board of Directors.…
Note: We are working on updating and enhancing the Canadian Drug Summaries. Not all reports published here have the most up-to-date information. Please check publication dates.
On January 25, 2021, colleagues from across the healthcare community will gather for a virtual conference on high-risk substance use and overdose among youth.
Ottawa, January 17, 2023 — According to the new Canada’s Guidance on Alcohol and Health, 3–6 standard drinks a week represents a moderate risk to your…
As an organization that conducts science and research, CCSA is dedicated to learning. As a learning organization, we are humbled by how much more we need to learn and understand from First Nations, Métis and Inuit.
A class of medications used to treat type 2 diabetes and obesity could help treat substance use disorders. GLP-1s, made popular by brands like Ozempic and Wegovy, show real promise in helping people curb cravings for substances like alcohol and…
“Don’t wait to seek help: Virtual care to support Canadians is available now,” urge mental health and substance use organizations
Ottawa, February 28, 2018 — On behalf of the Canadian Centre on Substance Use and Addiction (CCSA), I commend the Government of Canada for its strategic investments to address substance use and addiction in the…
Ottawa, April 25, 2019 — People who use cannabis regularly — one or more times per week over a period of months or years — could be at greater risk of developing psychosis or schizophrenia, according to a new report by the…
The Chair of CCSA’s Board of Directors, Vaughan Dowie makes the announcement and looks back on her remarkable career.
December 14, 2021
Dear colleagues,
